These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35095062)

  • 1. Effects of Aging and Hypertension on the Antithrombotic Function of Atrial Endocardium in Rats.
    Iwasaki YK; Sekiguchi A; Makabe R; Kato T; Yamashita T
    Int Heart J; 2022; 63(1):141-146. PubMed ID: 35095062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombomodulin and tissue factor pathway inhibitor in endocardium of rapidly paced rat atria.
    Yamashita T; Sekiguchi A; Iwasaki YK; Sagara K; Hatano S; Iinuma H; Aizawa T; Fu LT
    Circulation; 2003 Nov; 108(20):2450-2. PubMed ID: 14610015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin type 1 receptor blockade prevents endocardial dysfunction of rapidly paced atria in rats.
    Yamashita T; Sekiguchi A; Kato T; Tsuneda T; Iwasaki YK; Sagara K; Iinuma H; Sawada H; Aizawa T
    J Renin Angiotensin Aldosterone Syst; 2007 Sep; 8(3):127-32. PubMed ID: 17907100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocardial Changes in Nonvalvular Atrial Fibrillation Without Atrial Thrombus-Thrombomodulin and Tissue Factor Pathway Inhibitor.
    An K; Mei J; Zhu J; Tang M
    Clin Appl Thromb Hemost; 2018 Oct; 24(7):1148-1152. PubMed ID: 29364003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: potential mechanisms for atrial thrombosis and stroke.
    Cai H; Li Z; Goette A; Mera F; Honeycutt C; Feterik K; Wilcox JN; Dudley SC; Harrison DG; Langberg JJ
    Circulation; 2002 Nov; 106(22):2854-8. PubMed ID: 12451014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II receptor blockade reduces tachycardia-induced atrial adhesion molecule expression.
    Goette A; Bukowska A; Lendeckel U; Erxleben M; Hammwöhner M; Strugala D; Pfeiffenberger J; Röhl FW; Huth C; Ebert MP; Klein HU; Röcken C
    Circulation; 2008 Feb; 117(6):732-42. PubMed ID: 18227384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial endocardial expression of von Willebrand factor and thrombomodulin is associated with recurrence after minimally invasive surgical atrial fibrillation ablation.
    An K; Yin H; Mei J; Zhu J; Tang M
    Interact Cardiovasc Thorac Surg; 2018 Aug; 27(2):177-181. PubMed ID: 29547930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of Transient Receptor Potential Canonical Type 3 Channel via AT1R/TGF-
    He R; Zhang J; Luo D; Yu Y; Chen T; Yang Y; Yu F; Li M
    Oxid Med Cell Longev; 2019; 2019():4025496. PubMed ID: 31871548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic Dantrolene Treatment Does Not Affect Hypertension, but Attenuates Sympathetic Stimulation Enhanced Atrial Fibrillation Inducibility in SHR.
    Lee JS; Greco L; Migirov A; Li Y; Gerdes AM; Zhang Y
    Am J Hypertens; 2020 Apr; 33(5):407-413. PubMed ID: 32060500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial arrhythmia in ageing spontaneously hypertensive rats: unraveling the substrate in hypertension and ageing.
    Lau DH; Shipp NJ; Kelly DJ; Thanigaimani S; Neo M; Kuklik P; Lim HS; Zhang Y; Drury K; Wong CX; Chia NH; Brooks AG; Dimitri H; Saint DA; Brown L; Sanders P
    PLoS One; 2013; 8(8):e72416. PubMed ID: 24013508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanism and risk factors of cardiogenic thromboembolism in patients with atrial fibrillation].
    Otsuka T
    Nihon Rinsho; 2013 Jan; 71(1):36-40. PubMed ID: 23631169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects on atrial fibrillation in aged hypertensive rats by Ca(2+)-activated K(+) channel inhibition.
    Diness JG; Skibsbye L; Jespersen T; Bartels ED; Sørensen US; Hansen RS; Grunnet M
    Hypertension; 2011 Jun; 57(6):1129-35. PubMed ID: 21502564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition.
    Okazaki H; Minamino T; Tsukamoto O; Kim J; Okada K; Myoishi M; Wakeno M; Takashima S; Mochizuki N; Kitakaze M
    Hypertens Res; 2006 Apr; 29(4):277-84. PubMed ID: 16778335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simvastatin reduces platelet-endocardium adhesion in atrial fibrillation.
    Chello M; Spadaccio C; Patti G; Lusini M; Barbato R; Goffredo C; Di Sciascio G; Covino E
    Atherosclerosis; 2008 Apr; 197(2):588-95. PubMed ID: 17904146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation in pigs induces left atrial endocardial transcriptional remodelling.
    Cerveró J; Segura V; Macías A; Gavira JJ; Montes R; Hermida J
    Thromb Haemost; 2012 Oct; 108(4):742-9. PubMed ID: 22836863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiological properties of the human atrium in atrial fibrillation.
    Shimizu A; Centurion OA
    Cardiovasc Res; 2002 May; 54(2):302-14. PubMed ID: 12062336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left atrial endocardial fibrosis and intra-atrial thrombosis - landmarks of left atrial remodeling in rats with spontaneous atrial tachyarrhythmias.
    Scridon A; Tabib A; Barrès C; Julien C; Chevalier P
    Rom J Morphol Embryol; 2013; 54(2):405-11. PubMed ID: 23771089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of aging on atrial endocardial electrograms in patients with paroxysmal atrial fibrillation.
    Centurión OA; Isomoto S; Shimizu A; Konoe A; Kaibara M; Hirata T; Hano O; Sakamoto R; Hayano M; Yano K
    Clin Cardiol; 2003 Sep; 26(9):435-8. PubMed ID: 14524602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired activation of ATP-sensitive K+ channels in endocardial myocytes from left ventricular hypertrophy.
    Shimokawa J; Yokoshiki H; Tsutsui H
    Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3643-9. PubMed ID: 17921319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ticagrelor, but not clopidogrel active metabolite, displays antithrombotic properties in the left atrial endocardium.
    Reiner MF; Breitenstein A; Holy EW; Glanzmann M; Amstalden H; Stämpfli SF; Bonetti NR; Falk V; Keller S; Savarese G; Benussi S; Maisano F; Lüscher TF; Beer JH; Steffel J; Camici GG
    Eur Heart J; 2017 Mar; 38(12):916-919. PubMed ID: 28065908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.